Syros Provides Update on SELECT-AML-1 Phase 2 Clinical Trial

Stock Information for Syros Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Syros Pharmaceuticals Inc.

Syros Pharmaceuticals Inc Is Being Investigated For Possible Securities Fraud And Shareholders With Losses Are Encouraged To Contact The Schall Law Firm
The Schall Law Firm Urges Investor Participation In An Inquiry Into Syros Pharmaceuticals, Inc. For Securities Law Violations
Syros Pharmaceuticals Inc Is Being Investigated For Possible Securities Fraud And Affected Shareholders Are Encouraged To Contact The Schall Law Firm
The Schall Law Firm Urges Investors To Join An Inquiry Into Syros Pharmaceuticals, Inc. For Securities Law Violations
Syros Pharmaceuticals Inc Is Being Investigated For Possible Securities Fraud And Affected Shareholders Are Encouraged To Contact The Schall Law Firm
The Schall Law Firm Urges Investors To Join An Inquiry Into Syros Pharmaceuticals, Inc. For Securities Law Violations
Syros Pharmaceuticals Inc Is Being Investigated For Possible Securities Fraud And Affected Investors Are Encouraged To Contact The Schall Law Firm
The Schall Law Firm Urges Shareholder Participation In An Inquiry Into Syros Pharmaceuticals, Inc. For Securities Law Violations

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.